2012
DOI: 10.1007/s00404-012-2651-5
|View full text |Cite
|
Sign up to set email alerts
|

Endometrial metastases in breast cancer: a rare event

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…There are many diagnostic problems in confirming endometrial metastasis. Some criteria that must be met are: (1) Histopathologic features of the metastatic tumor should be identical to the original neoplasm, with no detection of coexisting primary neoplastic changes in the destination organ (uterus) [ 5 , 6 , 11 , 12 ]; (2) In known breast cancer patients, a hormone-induced (tamoxifen) endometrial neoplasm should be excluded; and (3) A consistent IHC is necessary to determine the original tumor (e.g., GCDFP15 and mammaglobin are specific and differentiating markers in favor of breast origin rather than primary endometrial carcinoma). GI malignancies usually express CK20 and CDx2 whereas endometrial and breast carcinoma are CK7-positive and CK20-negative.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are many diagnostic problems in confirming endometrial metastasis. Some criteria that must be met are: (1) Histopathologic features of the metastatic tumor should be identical to the original neoplasm, with no detection of coexisting primary neoplastic changes in the destination organ (uterus) [ 5 , 6 , 11 , 12 ]; (2) In known breast cancer patients, a hormone-induced (tamoxifen) endometrial neoplasm should be excluded; and (3) A consistent IHC is necessary to determine the original tumor (e.g., GCDFP15 and mammaglobin are specific and differentiating markers in favor of breast origin rather than primary endometrial carcinoma). GI malignancies usually express CK20 and CDx2 whereas endometrial and breast carcinoma are CK7-positive and CK20-negative.…”
Section: Discussionmentioning
confidence: 99%
“…GI malignancies usually express CK20 and CDx2 whereas endometrial and breast carcinoma are CK7-positive and CK20-negative. In breast cancers, those with tubule formation and positive reaction with E-Cadherin are ductal type [ 6 , 12 ]. Our patient’s IHC results were completely compatible with the prototype pattern of IDC.…”
Section: Discussionmentioning
confidence: 99%